1259532-01-8|THCCC|(7E)-7-Hydroxyimino-N-(4-methyl)phenyl-1,7a-dihydrocyclopropa[b]chromene-1a-carboxamide|-范德生物科技公司

THCCC

NMR下载 COA and HPLC MSDS下载
names：
(7E)-7-Hydroxyimino-N-(4-methyl)phenyl-1,7a-dihydrocyclopropa[b]chromene-1a-carboxamide
CAS号：
1259532-01-8
MDL Number：
MF(分子式)： C18H16N2O3 MW(分子量)： 308.33
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	(7E)-7-Hydroxyimino-N-(4-methyl)phenyl-1,7a-dihydrocyclopropa[b]chromene-1a-carboxamide
英文别名	THCCC;
CAS号	1259532-01-8
Inchi	InChI=1S/C18H16N2O3/c1-11-6-8-12(9-7-11)19-17(21)18-10-14(18)16(20-22)13-4-2-3-5-15(13)23-18/h2-9,14,22H,10H2,1H3,(H,19,21)/b20-16-
InchiKey	VKCTUZKPBYSTDW-SILNSSARSA-N
分子式 Formula	C18H16N2O3
分子量 Molecular Weight	308.33
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	THCCC(CAS:1259532-01-8):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	THCCC is a dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulator and a PHCCC analog.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Rabin KR, Poplack DG. Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15;25(4):328-35. Review. Erratum in: Oncology (Williston Park). 2011 May;25(6):55[1]PubMed PMID: 21618954.

[2]Kamdar KY, Rooney CM, Heslop HE. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant. 2011 Jun;16(3):274-80. doi: 10.1097/MOT.0b013e3283465715. Review. PubMed PMID: 21467936; PubMed Central PMCID: PMC3167800.

[3] Margolin JF. Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians. Eur J Pediatr. 2011 Apr;170(4):419-25. doi: 10.1007/s00431-011-1424-7. Epub 2011 Feb 25. Review. PubMed PMID: 21350806.

[4] Hockenberry MJ, McCarthy K, Taylor O, Scarberry M, Franklin Q, Louis CU, Torres L. Managing painful procedures in children with cancer. J Pediatr Hematol Oncol. 2011 Mar;33(2):119-27. doi: 10.1097/MPH.0b013e3181f46a65. Review. PubMed PMID: 21285907.

[5] Horton TM, Berg SL. Educational paper. The development of new therapies for pediatric oncology. Eur J Pediatr. 2011 May;170(5):555-9. doi: 10.1007/s00431-010-1374-5. Epub 2010 Dec 30. Review. PubMed PMID: 21190039.

6: Metelitsa LS. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol. 2011 Aug;140(2):119-29. doi: 10.1016/j.clim.2010.10.005. Epub 2010 Nov 20. Review. PubMed PMID: 21095162; PubMed Central PMCID: PMC3444285.7: Mueller BU. Hydroxyurea for children with sickle cell disease: are we starting too late? Pediatr Blood Cancer. 2011 Jan;56(1):3-4. doi: 10.1002/pbc.22858. Review. PubMed PMID: 21058289.8: Venkateswaran L, Yee DL. Rare bleeding disorders in young women. J Pediatr Adolesc Gynecol. 2010 Dec;23(6 Suppl):S38-42. doi: 10.1016/j.jpag.2010.08.011. Review. PubMed PMID: 20934892.9: Okur FV, Krance R. Stem cell transplantation in childhood non-Hodgkin's lymphomas. Curr Hematol Malig Rep. 2010 Oct;5(4):192-9. doi: 10.1007/s11899-010-0059-5. Review. PubMed PMID: 20661786.10: Huye LE, Dotti G. Designing T cells for cancer immunotherapy. Discov Med. 2010 Apr;9(47):297-303. Review. PubMed PMID: 20423673; PubMed Central PMCID: PMC2931319.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开